Are high prices turning new cancer medicines into unfulfilled promises?
The development of innovative new cancer medicines that meaningfully improve patient survival and quality of life is to be celebrated. But a new commentary from Common Sense Oncology published in The Lancet Oncology warns that spiraling prices risk turning these new treatments into unfulfilled promises, because they may not be accessible to the patients who […]